NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $511,295 | -35.9% | 6,810 | -0.8% | 0.01% | -41.7% |
| Q3 2021 | $797,275 | -17.6% | 6,863 | -6.3% | 0.01% | -14.3% |
| Q1 2021 | $967,822 | -26.9% | 7,322 | -4.3% | 0.01% | -30.0% |
| Q4 2020 | $1,324,102 | +182.8% | 7,652 | -3.1% | 0.02% | +150.0% |
| Q2 2020 | $468,233 | -77.2% | 7,896 | -71.3% | 0.01% | -77.1% |
| Q3 2019 | $2,055,702 | +38.6% | 27,490 | +17.2% | 0.04% | +40.0% |
| Q2 2019 | $1,482,680 | +31.3% | 23,449 | 0.0% | 0.02% | +25.0% |
| Q1 2019 | $1,129,538 | – | 23,449 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |